{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:04Z","timestamp":1786118584513,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1097\/01.ftd.0000249943.85160.13","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T05:36:23Z","timestamp":1165988183000},"page":"766-774","source":"Crossref","is-referenced-by-count":7,"title":["Mechanisms of Venoocclusive Disease Resulting From the Combination of Cyclophosphamide and Roxithromycin"],"prefix":"10.1097","volume":"28","author":[{"given":"Priska","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Haschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Beltinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrijn","family":"Bogman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kr\u00e4henb\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00001622-200203000-00001","article-title":"High-dose cyclophosphamide for aplastic anemia and autoimmunity.","volume":"14","author":"Brodsky","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s002280050201","article-title":"Characterization of the cytochrome P450 involved in side-chain oxidation of cyclophosphamide in humans.","volume":"51","author":"Bohnenstengel","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.1997.15.5.1885","article-title":"Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism.","volume":"15","author":"Busse","year":"1997","journal-title":"J Clin Oncol"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2435::AID-CNCR21>3.0.CO;2-R","article-title":"Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.","volume":"79","author":"Ortega","year":"1997","journal-title":"Cancer"},{"key":"R5-7-20210129","first-page":"467","article-title":"Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.","volume":"7","author":"Ozkaynak","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"R6-7-20210129","first-page":"171","article-title":"Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.","volume":"18","author":"Styler","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1345\/aph.1G441","article-title":"Hepatic Veno-Occlusive Disease Associated with Immunosuppressive Cyclophosphamide Dosing and Roxithromycin.","volume":"40","author":"Beltinger","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-2952(98)00133-6","article-title":"Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes.","volume":"56","author":"Yamazaki","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2131\/jts.21.4_215","article-title":"Effects of erythromycin and roxithromycin on oxidation of testosterone and nifedipine catalyzed by CYP3A4 in human liver microsomes.","volume":"21","author":"Yamazaki","year":"1996","journal-title":"J Toxicol Sci"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0703920","article-title":"HMG-CoA reductase inhibitors and P-glycoprotein modulation.","volume":"132","author":"Bogman","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02624456","article-title":"Spontaneous transformation and immortalization of human endothelial cells.","volume":"26","author":"Takahashi","year":"1990","journal-title":"In Vitro Cell Dev Biol"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004770-200009000-00005","article-title":"Lactate dehydrogenase leakage of hepatocytes with AH26 and AH Plus sealer treatments.","volume":"26","author":"Huang","year":"2000","journal-title":"J Endod"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/abio.1999.4197","article-title":"High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.","volume":"273","author":"Huang","year":"1999","journal-title":"Anal Biochem"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","article-title":"Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.","volume":"13","author":"Wacher","year":"1995","journal-title":"Mol Carcinog"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1023\/A:1018877803319","article-title":"Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.","volume":"16","author":"Kim","year":"1999","journal-title":"Pharm Res"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/0006-2952(94)00312-2","article-title":"Use of in vitro human metabolism studies in drug development. An industrial perspective.","volume":"48","author":"Rodrigues","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"R18-7-20210129","first-page":"367","article-title":"Hepatotoxicity due to mitochondrial dysfunction.","volume":"15","author":"Pessayre","year":"1999","journal-title":"Cell BiolToxicol"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/AAC.32.10.1541","article-title":"Toxicity, uptake, and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolide, and erythromycin base.","volume":"32","author":"Villa","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20634","article-title":"Mechanisms of benzarone and benzbromarone-induced hepatic toxicity.","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Hepatology"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1097(03)00100-9","article-title":"Role of oxidative stress and mitochondrial changes in cyanobacteria-induced apoptosis and hepatotoxicity.","volume":"220","author":"Ding","year":"2003","journal-title":"FEMS Microbiol Lett"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0891-5849(01)00632-3","article-title":"Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes.","volume":"31","author":"Qu","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis.","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/74994","article-title":"Mitochondrial control of cell death.","volume":"6","author":"Kroemer","year":"2000","journal-title":"Nat Med"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(03)00116-8","article-title":"Mitochondria: releasing power for life and unleashing the machineries of death.","volume":"112","author":"Newmeyer","year":"2003","journal-title":"Cell"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008571-200107000-00004","article-title":"Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.","volume":"11","author":"Lang","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bmt.1703319","article-title":"Apoptosis contributes to cyclophosphamide-induced cardiomyopathy.","volume":"29","author":"Beranek","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2002.01777.x","article-title":"Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.","volume":"128","author":"Strauss","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/mol.60.6.1268","article-title":"Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells.","volume":"60","author":"Schwartz","year":"2001","journal-title":"Mol Pharmacol"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1523-1747.2003.12022.x","article-title":"Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.","volume":"120","author":"Sharov","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/taap.2002.9414","article-title":"Teratogen-induced activation of caspase-9 and the mitochondrial apoptotic pathway in early postimplantation mouse embryos.","volume":"181","author":"Little","year":"2002","journal-title":"Toxicol Appl Pharmacol"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-03-3126","article-title":"Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.","volume":"64","author":"Hamano","year":"2004","journal-title":"Cancer Res"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/35004029","article-title":"The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant.","volume":"2","author":"Goldstein","year":"2000","journal-title":"Nat Cell Biol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.ftd.0000249943.85160.13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:15:55Z","timestamp":1786032955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200612000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ftd.0000249943.85160.13","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}